Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erectile dysfunction: interrelationship with the metabolic syndrome.

Glenn Matfin1, Ali Jawa, Vivian A Fonseca

  • 1Global Clinical Research, Novartis Pharmaceuticals, One Health Plaza, East Hanover, NJ 07936-1080, USA. glenn.matfin@pharma.novartis.com

Current Diabetes Reports
|January 25, 2005
PubMed
Summary

Erectile dysfunction (ED) is a marker for metabolic syndrome, indicating underlying vascular issues. Early evaluation and management of cardiovascular risk factors are crucial for patients with ED.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Broad-Spectrum Effects of Carbohydrate Reduction on Inflammatory and Immune Mediators in Type 2 Diabetes.

Endocrine research·2026
Same author

Cumulative effect of hyperglycemia and insulin resistance on cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.

American heart journal·2025
Same author

Greater alterations in atherogenic lipids and inflammatory markers in women during type 2 diabetes development and risk of coronary heart disease-Findings from two population-based studies.

Journal of clinical lipidology·2025
Same author

A Holistic Evaluation of Clinical Competence and Professional Attitudes in Diabetes Health Care: Insights From a Multinational Cohort.

Clinical diabetes : a publication of the American Diabetes Association·2025
Same author

Value-Based Pricing and Its Implications for the Newly Announced Medicare Negotiated Price Under the Inflation Reduction Act.

Diabetes care·2025
Same author

Sodium-glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real-world patients with type 2 diabetes.

Diabetes, obesity & metabolism·2024

Area of Science:

  • Endocrinology
  • Cardiology
  • Urology

Background:

  • Erectile dysfunction (ED) is prevalent in men with metabolic syndrome components.
  • ED serves as a potential risk marker for metabolic syndrome and associated conditions.
  • Endothelial dysfunction is a key factor linking metabolic syndrome, cardiovascular disease, and ED.

Purpose of the Study:

  • To highlight the association between ED and metabolic syndrome.
  • To emphasize the need for evaluating vascular disease in ED patients.
  • To underscore the importance of managing cardiovascular risk factors in ED management.

Main Methods:

  • Review of existing literature on ED and metabolic syndrome.
  • Analysis of the role of endothelial dysfunction in both conditions.

Related Experiment Videos

  • Clinical considerations for patient evaluation and risk factor modification.

    • Main Results:

    • ED is frequently observed alongside metabolic syndrome indicators.
    • Vascular disease evaluation is essential for men presenting with ED.
    • Addressing modifiable risk factors like smoking, diabetes, hypertension, and hyperlipidemia is critical.

    Conclusions:

    • ED management in metabolic syndrome patients requires understanding multifactorial etiology.
    • Clinicians must be aware of the pathophysiology to optimize patient outcomes.
    • Integrated management addressing metabolic and vascular health is recommended.